131I-Metuximab (brand name Licartin) is a radiolabeled murine antibody developed at the Fourth Military Medical University and brought on the market by the company Chengdu Huasun Technology Group The drug is targeting CD147 and was launched in China in 2006. The drug is only available in China.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.